Although anti‐mGluR5 encephalitis was first reported as paraneoplastic autoimmune encephalitis, the increasing number of reported nontumor cases suggests that anti‐mGluR5 encephalitis may have a lower risk of a combined tumor(< 30%). Here, GRM5 is linked to neoplasm.